希瑪眼科(03309.HK)料中績倍增股價漲23%越牛熊線成交激增
希瑪眼科(03309.HK)發盈喜料中績倍增,該股今早大裂口高開,最多急漲26%高見5.57元,一舉升破百天線及牛熊線(4.76元5.13元),現造5.46元,急漲23%,成交激增至2,866萬股,為逾半年最多,涉資1.518億元。
希瑪發盈喜指,受惠首五個月收益增逾30%,以及去年開始營業北京眼科醫院淨虧損減少及人民幣計值銀行存款減少所產生外匯虧損金額減少,預計今年上半年淨利潤按年增逾1倍。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.